Evaluation of child with fever without source: Review of literature and update

Pediatric Clinics of North America

Volumn 60, Issue 5, 2013, Pages 1049-1062

  Arora, Rajan ^a   Mahajan, Prashant ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fever; Fever without source; Serious bacterial infection; Tissue culture

Indexed keywords

ACICLOVIR; ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CEPHALOSPORIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; PNEUMOCOCCUS VACCINE; PROCALCITONIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIURIA; CEREBROSPINAL FLUID EXAMINATION; CHILD CARE; CIRCUMCISION; CLINICAL DECISION MAKING; DISEASE SEVERITY; DISEASE SURVEILLANCE; EMERGENCY CARE; ENTEROCOCCUS; ESCHERICHIA COLI; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HERD IMMUNITY; HUMAN; IMMUNOREGULATION; INFECTION RISK; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LISTERIA MONOCYTOGENES; LUMBAR PUNCTURE; MENINGOCOCCEMIA; MORAXELLA CATARRHALIS; NEISSERIA MENINGITIDIS; NEUTROPHIL COUNT; NEWBORN CARE; OUTPATIENT CARE; PATIENT CODING; PNEUMOCOCCAL MENINGITIS; PRACTICE GUIDELINE; PROGNOSIS; PROTEIN BLOOD LEVEL; PYREXIA IDIOPATHICA; PYURIA; RAPID TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RISK ASSESSMENT; SALMONELLA; SCREENING TEST; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; VACCINATION; VIRUS DETECTION; VIRUS LOAD;

FEVER; FEVER WITHOUT SOURCE; SERIOUS BACTERIAL INFECTION; TISSUE CULTURE;

BACTERIAL INFECTIONS; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEVER OF UNKNOWN ORIGIN; HUMANS; INFANT; INFANT, NEWBORN; MASS SCREENING; RISK FACTORS;

EID: 84884816587     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2013.06.009     Document Type: Review

References (59)

1. Chamberlain J.M., Patel K.M., Pollack M.M. Association of emergency department care factors with admission and discharge decisions for pediatric patients. JPediatr 2006, 149(5):644-649.
2. Mahajan P, Knazik S, Chen X. Evaluation of febrile infants <60 days of age: review of NHAMCS data. PAS: Pediatric Academic Societies Annual Meeting, May 6, 2008. Toronto.
3. McCaig L.F., Nawar E.W. National Hospital Ambulatory Medical Care Survey: 2004 emergency department summary. Adv Data 2006, (372):1-29.
4. Baraff L.J., Bass J.W., Fleisher G.R., et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med 1993, 22(7):1198-1210.
5. Lee G.M., Fleisher G.R., Harper M.B. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics 2001, 108:835-844.
6. Bachur R.G., Harper M.B. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics 2001, 108(2):311-316.
7. Harper M. Update on the management of the febrile infant. Clin Pediatr Emerg Med 2004, 5(1):5-12.
8. Baker M.D., Avner J.R. The febrile infant: what's new?. Clin Pediatr Emerg Med 2008, 9(4):213-220.
9. Kramer M.S., Etezadi-Amoli J., Ciampi A., et al. Parents' versus physicians' values for clinical outcomes in young febrile children. Pediatrics 1994, 93:697-702.
10. Eagles D., Stiell I.G., Clement C.M., et al. International survey of emergency physicians' priorities for clinical decision rules. Acad Emerg Med 2008, 15(2):177-182.
11. Burke J.P., Klein J.O., Gezon H.M., et al. Pneumococcal bacteremia. Review of 111 cases, 1957-1969, with special reference to cases with undetermined focus. Am J Dis Child 1971, 121(4):353-359.
12. Jaffe D.M., Tanz R.R., Davis A.T., et al. Antibiotic administration to treat possible occult bacteremia in febrile children. NEngl J Med 1987, 317(19):1175-1180.
13. Bass J.W., Steele R.W., Wittler R.R., et al. Antimicrobial treatment of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis J 1993, 12(6):466-473.
14. Waddle E., Jhaveri R. Outcomes of febrile children without localizing signs after pneumococcal conjugate vaccine. Arch Dis Child 2009, 94(2):144-147.
15. Wilkinson M., Bulloch B., Smith M. Prevalence of occult bacteremia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era. Acad Emerg Med 2009, 16(3):220-225.
16. Mintegi S., Benito J., Sanchez J., et al. Predictors of occult bacteremia in young febrile children in the era of heptavalent pneumococcal conjugated vaccine. Eur J Emerg Med 2009, 16(4):199-205.
17. Herz A.M., Greenhow T.L., Alcantara J., et al. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J 2006, 25(4):293-300.
18. Greenhow T.L., Hung Y.Y., Herz A.M. Changing epidemiology of bacteremia in infants aged 1 week to 3 months. Pediatrics 2012, 129(3):e590-e596.
19. Freedman A.L. Urologic diseases in North America project: trends in resource utilization for urinary tract infections in children. JUrol 2005, 173:949-954.
20. American Academy of Pediatrics, Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011, 128(3):595-610.
21. Shaikh N., Morone N.E., Bost J.E., et al. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 2008, 27(4):302-308.
22. Gorelick M.H., Shaw K.N. Clinical decision rule to identify febrile young girls at risk for urinary tract infection. Arch Pediatr Adolesc Med 2000, 154(4):386-390.
23. Kaplan S.L., Mason E.O., Wald E.R., et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004, 113(3):443-449.
24. Tsai C.J., Griffin M.R., Nuorti J.P., et al. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 2008, 46(11):1664-1672.
25. American College of Emergency Physicians Clinical Policies Committee, American College of Emergency Physicians Clinical Policies Subcommittee on Pediatric Fever Clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med 2003, 42:530-545.
26. Murphy C.G., van de Pol A.C., Harper M.B., et al. Clinical predictors of occult pneumonia in the febrile child. Acad Emerg Med 2007, 14(3):243-249.
27. Mintegi S., Benito J., Pijoan J.I., et al. Occult pneumonia in infants with high fever without source a prospective multicenter study. Pediatr Emerg Care 2010, 26(7):470-474.
28. Colvin J.M., Muenzer J.T., Jaffe D.M., et al. Detection of viruses in young children with fever without an apparent source. Pediatrics 2012, 130(6):e1455-e1462.
29. Ramers C., Billman G., Hartin M., et al. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 2000, 283(20):2680-2685.
30. Benito-Fernandez J., Vazquez-Ronco M.A., Morteruel-Aizkuren E., et al. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Pediatr Infect Dis J 2006, 25(12):1153-1157.
31. Smitherman H.F., Caviness A.C., Macias C.G. Retrospective review of serious bacterial infections in infants who are 0 to 36 months and have influenza A infection. Pediatrics 2005, 115(3):710-718.
32. Levine D.A., Platt S.L., Dayan P.S., et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 2004, 113(6):1728-1734.
33. Krief W., Levine D., Platt S., et al. Influenza virus infection and the risk of serious bacterial infections in young febrile infants. Pediatrics 2009, 124(1):30-39.
34. Hui C., Neto G., Tsertsvadze A., et al. Diagnosis and management of febrile infants (0-3 months) 2012, Agency for Healthcare Research and Quality (US), Rockville (MD), (Evidence Report/Technology Assessments, No. 205). Available at:, Accessed March 4, 2013. http://www.ncbi.nlm.nih.gov/books/NBK92690/.
35. Hsiao A.L., Baker M.D. Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children. Curr Opin Pediatr 2005, 17(1):56-61.
36. Kuppermann N. Occult bacteremia in young febrile children. Pediatr Clin North Am 1999, 46(6):1073-1109.
37. Galetto-Lacour A., Gervaix A. Identifying severe bacterial infection in children with fever without source. Expert Rev Anti Infect Ther 2010, 8(11):1231-1237.
38. Kuppermann N., Malley R., Inkelis S.H., et al. Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease. Pediatrics 1999, 103(2):E20.
39. Zaidi E., Bachur R., Harper M. Non-typhi Salmonella bacteremia in children. Pediatr Infect Dis J 1999, 18(12):1073-1077.
40. Van den Bruel A., Thompson M.J., Haj-Hassan T., et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ 2011, 342:d3082.
41. Carrol E.D., Newland P., Riordan F.A., et al. Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child 2002, 86(4):282-285.
42. Fernández Lopez A., Luaces Cubells C., García García J.J., et al. Procalcitonin in pediatric emergency departments for early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and the utility of a rapid qualitative test for this marker. Pediatr Infect Dis J 2003, 22(10):895-903.
43. Lacour A.G., Gervaix A., Zamora S.A., et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localizing signs. Eur J Pediatr 2001, 160(2):95-100.
44. Thayyil S., Shenoy M., Hamaluba M., et al. Is procalcitonin useful in early diagnosis of serious bacterial infections in children?. Acta Paediatr 2005, 94(2):155-158.
45. Sanders S., Barnett A., Correa-Velez I., et al. Systematic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in non-hospitalized infants and children with fever. JPediatr 2008, 153(4):570-574.
46. Herd D. In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus?. Arch Dis Child 2007, 92(4):362-364.
47. Jones A.E., Fiechtl J.F., Brown M.D., et al. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007, 50(1):34-41.
48. McGinn T.G., Guyatt G.H., Wyer P.C., et al. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA 2000, 284:79-84.
49. Craig J.C., Williams G.J., Jones M., et al. The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15781 febrile illnesses. BMJ 2010, 340:c1594.
50. Lacour A.G., Zamora S.A., Gervaix A. Ascore identifying serious bacterial infections in children with fever without source. Pediatr Infect Dis J 2008, 27:654-656.
51. Galetto-Lacour A., Zamora S.A., Andreola B., et al. Validation of a laboratory risk index score for the identification of severe bacterial infection in children with fever without source. Arch Dis Child 2010, 95:968-973.
52. Bressan S., Gomez B., Mintegi S., et al. Diagnostic performance of the lab-score in predicting severe and invasive bacterial infections in well-appearing young febrile infant. Pediatr Infect Dis J 2012, 31(12):1239-1244.
53. Pantell R.H., Newman T.B., Bernzweig J., et al. Management and outcomes of care in fever in early infancy. JAMA 2004, 291(10):1203-1212.
54. DeAngelis C., Joffe A., Wilson M., et al. Iatrogenic risks and financial costs of hospitalizing febrile infants. Am J Dis Child 1983, 137(12):1146-1149.
55. Sard B., Bailey M.C., Vinci R. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department. Pediatr Emerg Care 2006, 22:295-300.
56. Relman D.A. The human body as microbial observatory. Nat Genet 2002, 30(2):131-133.
57. Azzari C., Moriondo M., Indolfi G., et al. Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. JMed Microbiol 2008, 57:1205-1212.
58. Poritz M.A., Blaschke A.J., Byington C.L., et al. Film array, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One 2011, 6(10):e2604.
59. Ramilo O., Allman W., Chung W., et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007, 109(5):2066-2077.